USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA
关于老挝专利「USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA」，老商通整理了如下公开信息，由 SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. 于 2021-02-02 提交申请，当前状态为等待形式审查。标识字段包括：申请号 P/845；DIP 编号 LAP845；主管局代码 LA；保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。国际分类 / IPC 标注为 A61K 31/045、A61K 33/06、A61K 36/78、A61K 9/14、A61K 9/48、A61P 11/00、A61P 31/14。发明人 / 设计人包括 JIA, Zhenhua。代理机构 / 代理人记载为 CONCETTI-LAO CO., LTD。公开摘要提示：Use of a pharmaceutical composition in the preparation of a medicament for preventing and treating novel coronavirus-infected pneumonia. Th…。
LaoBiz profiles the Laos patent “USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA” from open registry fields, filed by SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. on 2021-02-02; current status: Awaiting formal examination. Identifiers include application No. P/845; DIP id LAP845; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/045、A61K 33/06、A61K 36/78、A61K 9/14、A61K 9/48、A61P 11/00、A61P 31/14. Inventor(s)/designer(s): JIA, Zhenhua. Abstract hint: Use of a pharmaceutical composition in the preparation of a medicament for preventing and treating novel coronavirus-infected pneumonia. Th…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
ໜ້ານີ້ສະຫຼຸບ ສິດທິບັດ «USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. ໃນວັນທີ 2021-02-02; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/845; ລະຫັດ DIP LAP845; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-02-27. ປະເພດ/ຫ້ອງ: A61K 31/045、A61K 33/06、A61K 36/78、A61K 9/14、A61K 9/48、A61P 11/00、A61P 31/14. ນັກປະດິດ/ນັກອອກແບບ: JIA, Zhenhua. ສະຫຼຸບ: Use of a pharmaceutical composition in the preparation of a medicament for preventing and treating novel coronavirus-infected pneumonia. Th…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.
P/845
图样
基础信息
- 类型
- 专利
- 申请号
P/845- 状态
- 等待形式审查
- 申请人
- SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
- 代理机构
- CONCETTI-LAO CO., LTD
- 申请日期
- 2021-02-02
- 公开/公告日
- 2026-02-27
- 国际分类
- A61K 31/045 · A61K 33/06 · A61K 36/78 · A61K 9/14 · A61K 9/48 · A61P 11/00 · A61P 31/14
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
Use of a pharmaceutical composition in the preparation of a medicament for preventing and treating novel coronavirus-infected pneumonia. The pharmaceutical composition is prepared from forsythia, honeysuckle, isatis root, Rheum officinale, Pogostemon cablin, Rhizoma Dryopteris Crassirhizomae, Rhodiola rosea, menthol, honey-fried Herba ephedra, fried Semen Armeniacae Amarae, Houttuynia cordate, liquorice and gypsum fibrosum. It is experimentally verified that the pharmaceutical composition has the effect of preventing and treating novel coronavirus-infected pneumonia.
Use of a pharmaceutical composition in the preparation of a medicament for preventing and treating novel coronavirus-infected pneumonia. The pharmaceutical composition is prepared from forsythia, honeysuckle, isatis root, Rheum officinale, Pogostemon cablin, Rhizoma Dryopteris Crassirhizomae, Rhodiola rosea, menthol, honey-fried Herba ephedra, fried Semen Armeniacae Amarae, Houttuynia cordate, liquorice and gypsum fibrosum. It is experimentally verified that the pharmaceutical composition has the effect of preventing and treating novel coronavirus-infected pneumonia.